LONDON, Nov. 20, 2017 /PRNewswire/ --
Hemostasis Diagnostics Market: Scope and Methodology
This report on the global hemostasis diagnostics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global hemostasis diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
Download the full report: https://www.reportbuyer.com/product/5207219
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the hemostasis diagnostics market such as augmentation in online services, increase in acceptance of disposable products and miniaturization. The key market indicators influencing global hemostasis diagnostics market taken into consideration including cost constraints and regulatory landscape. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global hemostasis diagnostics market. The report also highlights key events of the global hemostasis diagnostics industry. A porter's five force analysis highlighting competitive landscape is also included in the report.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. The year on year growth of global hemostasis diagnostics market for each segment is also reflected. Additionally, market related factors such as technological advancements, rise in POCT in developed countries, and cost reduction for hospitals and greater affordability for patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Hemostasis Diagnostics Market: Segmentation
Based on product type, the global hemostasis diagnostics market has been segmented into laboratory systems, consumables, and point-of-care testing systems. On the basis of test type the market has been segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, d dimer, and others. Based on end-user, the market has been segmented into hospital/clinics, independent diagnostic laboratories, home care settings, and others. Hospitals segment is expected to remain dominant during the forecast period.
Geographically, the global hemostasis diagnostics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, India, Japan, Brazil, and Mexico.
Hemostasis Diagnostics Market: Competitive Landscape
The report also profiles major players in the hemostasis diagnostics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the hemostasis diagnostics market is provided in the report. Key companies profiled in the report include Abbott Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Siemens Healthineers, Instrumentation Laboratory, Danaher Corporation (Beckman Coulter), and Grifols, S.A.
The global hemostasis diagnostics market has been segmented as follows:
Global Hemostasis Diagnostics Market, by Product
Laboratory Systems
Automated Systems
Semi-automated Systems
Manual Systems
Consumables
Point-of-Care Testing Systems
Global Hemostasis Diagnostics Market, By Test Type
Prothrombin Test Time (PT)
Activated partial thromboplastin time (APTT)
Fibrinogen degradation products (FDP)
Activated Clotting Time
Platelet Aggregation Test
D Dimer
Others
Global Hemostasis Diagnostics Market, by End-user
Hospital/Clinics
Independent Diagnostic Laboratories
Home Care Settings
Others
Global Hemostasis Diagnostics Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC
Rest of Middle East & Africa
Download the full report: https://www.reportbuyer.com/product/5207219
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/hemostasis-diagnostics-market---global-industry-analysis-size-share-growth-trends-and-forecast-2017---2025-300559882.html
SOURCE ReportBuyer
